Free Newsletter
Molecular research points to new obesity therapy
A team of Japanese researchers at the department of medicine and molecular science at Gunma University Graduate School of Medicine have found a molecule that suppresses appetite in animals, raising the prospect that they have found a new way to treat obesity. Infusing rats with nesfatin-1 over a 10 day period, they ate less food than untreated rats--12.6 grams versus 30.4 grams--without any signs of adverse events. The scientists focused on the NUCB2 protein in the brain that helps people regulate their appetite. They took a molecule, dubbed it nesfatin-1, and conducted their research with a group of obese rats bred with a gene mutation that made them resistant to leptin, which evidently plays a role in promoting obesity among people. The researchers then blocked the effect of nesfatin-1 in a group of rats and saw their weight balloon. Their work is published in the October 1 online edition of Nature.
- here's the HealthDay report on the research
Comments
This is amazing ! this Nesfatin-1 could block people apetite due to its action on LEPTIN WHICH PLAYS A ROLE IN PROMOTING OBESITY. IS THAT SAYING THAT IT WILL STOP PEOPLE'S APETITE FOR SUCH FOODs AS SIZZLING STEAK, BARBECUE CHICKEN, k-bOBS, & CRAVING FOR SWEETIES & MOUTH-WATERING DESSERTS !
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: